Ulcerative colitis trials in Jordan
4 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 2Enrolling by invitationLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Amman, Irbid
- Age
- 18 years and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - Phase 1/2Taking peopleStudy of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Where
- Amman, Irbid
- Age
- 18 years to 75 years
- People
- 270 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06619990 - Phase 2Taking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Amman, Irbid
- Age
- 18 years to 75 years
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - Phase 2Taking peopleSafety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
- Where
- Amman, Irbid
- Age
- 18 years to 75 years
- People
- 57 worldwide
- Run by
- Odyssey Therapeutics, Inc.
See details and how to joinNCT06850727